Alnylam Pharmaceuticals | ALNY - Revenu Net





Revenu Net Changement Date
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 2.41B 1.52B 2025-12
PTC Therapeutics USD -2.81M 132.16M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY -24.32B 127.96B 2026-03
Tectonic Therapeutic USD -19.23M 186K 2025-12
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Xencor USD -128.92M 122.26M 2026-03